MedTrace Logo

Measuring Outcomes of LASIK and EVO-ICL in Matched Populations

NCT06700460 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-01-09

No results posted yet for this study

Summary

Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.

Conditions

  • Myopia

Interventions

DEVICE

Laser-assisted in Situ Keratomileusis

LASIK

DEVICE

Implantable Collamer Lens placement

EVO ICL

Sponsors & Collaborators

  • Vance Thompson Vision

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-27
Primary Completion
2025-02-28
Completion
2025-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06700460 on ClinicalTrials.gov